首页> 外国专利> SYNERGISTIC COMBINATIONS OF SYNTHETIC LYSINE ANALOGS, DERIVATIVES, MIMETICS, OR PRODRUGS AND PHARMACEUTICAL AGENTS FOR ENHANCED EFFICACY

SYNERGISTIC COMBINATIONS OF SYNTHETIC LYSINE ANALOGS, DERIVATIVES, MIMETICS, OR PRODRUGS AND PHARMACEUTICAL AGENTS FOR ENHANCED EFFICACY

机译:合成赖氨酸类似物,衍生物,模拟物或前药和药剂的协同组合,用于增强疗效

摘要

In an embodiment, the present disclosure pertains to a composition to enhance efficacy of a pharmaceutical agent. In some embodiments, the composition includes a synthetic lysine analog, derivative, mimetic, or prodrog and the pharmaceutical agent. In some embodiments, the synthetic lysine analog, derivative, mimetic, or prodrug and the antiviral agent form a synergistic combination. In an additional embodiment, the present disclosure pertains to a method to enhance efficacy of the pharmaceutical agent that generally includes administering the synergistic combination to a subject in need thereof. In a further embodiment, the present disclosure pertains to a kit to enhance efficacy of the pharmaceutical agent that generally includes the synergistic combination.
机译:在一个实施方案中,本公开涉及一种组合物,以增强药剂的功效。在一些实施方案中,该组合物包括合成赖氨酸类似物,衍生物,模拟物或前驱和药剂。在一些实施方案中,合成赖氨酸类似物,衍生物,模拟物或前药和抗病毒剂形成协同组合。在另外的实施方案中,本公开涉及增强药剂的功效的方法,所述药剂通常包括向有此需要的受试者施用协同组合。在另一个实施方案中,本公开涉及一种试剂盒,以增强通常包括协同组合的药剂的功效。

著录项

  • 公开/公告号WO2021087058A1

    专利类型

  • 公开/公告日2021-05-06

    原文格式PDF

  • 申请/专利权人 TRANEXAMIC TECHNOLOGIES LLC;

    申请/专利号WO2020US57877

  • 发明设计人 STEWART W. PAUL;MURDOCK FRANK;

    申请日2020-10-29

  • 分类号A61K31/195;A61K47/18;A61K9/08;

  • 国家 US

  • 入库时间 2022-08-24 18:36:28

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号